🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 5

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 5 of 9
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Nov 19, 2025 at 2:52 AM#21

Congrats NurseAsh_DET!! You should be so proud of yourself. 🎉

Last edited: Nov 19, 2025 at 8:52 AM
21 23Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 18 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Nov 19, 2025 at 3:09 AM#22

Reading this thread on Can we talk about how hits close to home. Dad of 2 checking in — I started at 277 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 52 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Can we talk about — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Nov 19, 2025 at 5:09 AM
31 20Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 28 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Nov 19, 2025 at 3:26 AM#23

As a healthcare provider, I want to add some clinical context to this discussion on Can we talk about how SLOW the FDA is .

Building on what CanadaChris said — the evidence base here is well-established. The key publications to reference are from the SELECT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Nov 19, 2025 at 4:26 AM
42 8LindaRN_retired, tommy_boulder, hyun_seoul and 39 others
Reply Quote Save Share Report
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Nov 19, 2025 at 3:43 AM#24

RegAffairsDC — wow. This community is amazing.

Last edited: Nov 19, 2025 at 4:43 AM
42 18bri_stats, pete_manc_UK, anna.melb_AU and 39 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Nov 19, 2025 at 4:00 AM#25

Adding my data to this Can we talk about how discussion:

MetricBaselineMonth 5Month 8
Weight270 lbs230 lbs215 lbs
A1C6.4%6.0%5.4%
hsCRP4.04.01.2

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.2g/kg/day.

37 23julia.endo, JessicaM_2024, TomFromTexas and 34 others
Reply Quote Save Share Report
1345679

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register